ASTRAZENECA PLC Annual Research And Development Expense in USD from 2015 to 2024

Taxonomy & unit
ifrs-full: USD
Summary
Astrazeneca Plc annual/quarterly Research And Development Expense history and growth rate from 2015 to 2024.
  • Astrazeneca Plc Research And Development Expense for the quarter ending June 30, 2024 was $3.01B, a 12.8% increase year-over-year.
  • Astrazeneca Plc annual Research And Development Expense for 2024 was $13.6B, a 24.2% increase from 2023.
  • Astrazeneca Plc annual Research And Development Expense for 2023 was $10.9B, a 12% increase from 2022.
  • Astrazeneca Plc annual Research And Development Expense for 2022 was $9.76B, a 0.27% increase from 2021.
Research And Development Expense, Annual (USD)
Research And Development Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $13.6B +$2.65B +24.2% Jan 1, 2024 Dec 31, 2024 20-F 2025-02-18
2023 $10.9B +$1.17B +12% Jan 1, 2023 Dec 31, 2023 20-F 2025-02-18
2022 $9.76B +$26M +0.27% Jan 1, 2022 Dec 31, 2022 20-F 2025-02-18
2021 $9.74B +$3.75B +62.5% Jan 1, 2021 Dec 31, 2021 20-F 2024-02-20
2020 $5.99B -$68M -1.12% Jan 1, 2020 Dec 31, 2020 20-F 2023-02-21
2019 $6.06B +$127M +2.14% Jan 1, 2019 Dec 31, 2019 20-F 2022-02-22
2018 $5.93B +$175M +3.04% Jan 1, 2018 Dec 31, 2018 20-F 2021-02-16
2017 $5.76B -$133M -2.26% Jan 1, 2017 Dec 31, 2017 20-F 2020-03-03
2016 $5.89B -$107M -1.78% Jan 1, 2016 Dec 31, 2016 20-F 2019-03-05
2015 $6B Jan 1, 2015 Dec 31, 2015 20-F 2018-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.